Legal Opinion
Grunenthal Gmbh v. Alkem Laboratories Limited
Court of Appeals for the Federal Circuit
Decided March 28, 2019No. 2017-1153; 2017-2048; 2017-2049; 2017-2050PublishedCited by 25 opinions
1Opinion of the Court
Reyna, Circuit Judge.
*1336 Alkem Laboratories Limited, Hikma Pharmaceuticals International Limited, and Hikma Pharmaceuticals USA Inc. appeal the judgment of the district court that U.S. Patent No. 7,994,364 is not invalid for obviousness or lack of utility. Grünenthal GmbH and Assertio Therapeutics, Inc., formerly Depomed, Inc., cross-appeal the finding that Hikma Pharmaceuticals International Limited, Hikma Pharmaceuticals USA Inc., and Actavis Elizabeth LLC do not infringe U.S. Patent No. 8,536,130 . Because the district court did not err in its conclusions, we affirm.
BACKGROUND
A. Patents at…
2Cases cited25 opinions
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Pfizer, Inc. v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2007
- Vita-Mix Corp. v. Basic Holding, Inc.Court of Appeals for the Federal Circuit · 2009
- Raytheon Company, Appellee/cross-Appellant v. Roper Corporation, Appellant/cross-AppelleeCourt of Appeals for the Federal Circuit · 1983
- Brooktree Corporation, Plaintiff/cross-Appellant v. Advanced Micro Devices, Inc.Court of Appeals for the Federal Circuit · 1993
20 more not listed; retrieve them via the Exa API.
3Cited by25 opinions
- Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc.Court of Appeals for the Federal Circuit · 2024
- Genentech, Inc. v. Sandoz Inc.Court of Appeals for the Federal Circuit · 2022
- Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2024
- H. Lundbeck A/S v. Lupin Ltd.Court of Appeals for the Federal Circuit · 2023
- Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2025
20 more not listed; retrieve them via the Exa API.